Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial
Burd, Amy, Levine, Ross L, Ruppert, Amy S, Mims, Alice S, Borate, Uma, Stein, Eytan M, Patel, Prapti, Baer, Maria R, Stock, Wendy, Deininger, Michael, Blum, William, Schiller, Gary, Olin, Rebecca, Litzow, Mark, Foran, James, Lin, Tara L, Ball, Brian, Boyiadzis, Michael, Traer, Elie, Odenike, Olatoyosi, Arellano, Martha, Walker, Alison, Duong, Vu H, Kovacsovics, Tibor, Collins, Robert, Shoben, Abigail B, Heerema, Nyla A, Foster, Matthew C, Vergilio, Jo-Anne, Brennan, Tim, Vietz, Christine, Severson, Eric, Miller, Molly, Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley, Chen, Timothy, Stefanos, Mona, Druker, Brian, Byrd, John C
Published in Nature medicine (01.12.2020)
Published in Nature medicine (01.12.2020)
Get full text
Journal Article
Real‐world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
Byrd, John C., Gatz, Jennifer L., Louis, Cynthia Lim, Mims, Alice S., Borate, Uma, Yocum, Ashley O., Gana, Theophilus J., Burd, Amy
Published in Cancer medicine (Malden, MA) (01.09.2023)
Published in Cancer medicine (Malden, MA) (01.09.2023)
Get full text
Journal Article
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Cai, Sheng F., Huang, Ying, Lance, Jennie R., Mao, Charlene, Dunbar, Andrew J., McNulty, Samantha N., Druley, Todd, Li, Yan, Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William G., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark, Lin, Tara, Patel, Prapti, Foster, Matthew C., Boyiadzis, Michael, Collins, Robert H., Chervin, Jordan, Shoben, Abigail, Vergilio, Jo-Anne, Heerema, Nyla A., Rosenberg, Leonard, Chen, Timothy L., Yocum, Ashley O., Druggan, Franchesca, Marcus, Sonja, Stefanos, Mona, Druker, Brian J., Mims, Alice S., Borate, Uma, Burd, Amy, Byrd, John C., Levine, Ross L., Stein, Eytan M.
Published in Blood advances (23.01.2024)
Published in Blood advances (23.01.2024)
Get full text
Journal Article
P512: A PHASE 1B/2 STUDY OF TP‐0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS
Mims, Alice, Huang, Ying, Eisenmann, Eric, Orwick, Shelley, Buelow, Daelynn, Swords, Ronan, Zeidner, Joshua, Foster, Matthew, L. Lin, Tara, Baer, Maria, Madanat, Yazan, Kovacsovics, Tibor, Redner, Robert, Al‐Mansour, Zeina, Stefanos, Mona, Martycz, Molly, Druggan, Franchesca, Chen, Timothy, Yocum, Ashley, Borate, Uma, Druker, Brian, Burd, Amy, Levine, Ross, Baker, Sharyn, C. Byrd, John
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
A tissue-specific chromatin loop activates the erythroid ankyrin-1 promoter
Yocum, Ashley O., Steiner, Laurie A., Seidel, Nancy E., Cline, Amanda P., Rout, Emily D., Lin, Jolinta Y., Wong, Clara, Garrett, Lisa J., Gallagher, Patrick G., Bodine, David M.
Published in Blood (25.10.2012)
Published in Blood (25.10.2012)
Get full text
Journal Article
Is Disease Response a Patient-Centered Clinical Trial Endpoint in Acute Myeloid Leukemia: Differences in Symptom Burden and Physical Function By Response Status in the Beat-AML Master Trial
Bennett, Antonia V., Tan, Xianming, Foster, Matthew C., Richardson, Daniel R., Bryant, Ashley L., Wood, William A., Yocum, Ashley O., Mims, Alice S., Borate, Uma, Burd, Amy
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A Retrospective Observational Real-World Study of the Characteristics, Genomic Analysis, Treatment Patterns and Outcomes of Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) in the United States
Byrd, John C., Gatz, Jennifer L, Cripe, Larry D., Lim Louis, Cynthia, Mims, Alice S., Borate, Uma, Yocum, Ashley O., Gana, Theophilus, Burd, Amy
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
A Randomized Phase 2 Trial of 28-Day (Arm A) Versus 14-Day (Arm B) Schedule of Venetoclax + Azacitidine in Newly Diagnosed Acute Myeloid Leukemia Patients ≥ 60 Years
Borate, Uma M., Huang, Ying, Johnson, Mary F., Zeidner, Joshua F., Swords, Ronan T., Koenig, Kristin L, Stein, Eytan M., Baer, Maria R., Stock, Wendy, Madanat, Yazan F., Olin, Rebecca, Blum, William, Schiller, Gary J., Lin, Tara L, Redner, Robert L., Curran, Emily K, Heerema, Nyla A., Martycz, Molly, Rosenberg, Leonard, Marcus, Sonja Gullen, Chen, Timothy, Stefanos, Mona, Levine, Ross L, Druker, Brian J., Yocum, Ashley Owen, Burd, Amy, Mims, Alice, Byrd, John C.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A phase 1b/2 study of TP-0903 and decitabine targeting mutant TP53 and/or complex karyotype in patients with untreated acute myeloid leukemia ≥ age 60 years: Phase 1b interim results
Mims, Alice S., Huang, Ying, Eisenmann, Eric, Buelow, Daelynn, Swords, Ronan T., Foster, Matthew Charles, Lin, Tara L., Baer, Maria R., Kovacsovics, Tibor, Al-Mansour, Zeina, Stefanos, Mona, Druggan, Franchesca, Chen, Timothy, Yocum, Ashley, Borate, Uma, Druker, Brian J., Burd, Amy, Levine, Ross L., Baker, Sharyn D., Byrd, John C.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Beat AML S8 Group 2: Gilteritinib (GILT) in Combination with Decitabine (DEC) and Venetoclax (VEN) in Untreated FLT3 Mutated Acute Myeloid Leukemia (AML) Patients Age ≥60 with High and Low Variant Allele Frequency (VAF)
Liu, Qiuying (Selina), Welkie, Rina Li, Huang, Ying, Swords, Ronan T., Lin, Tara L, Koenig, Kristin L, Madanat, Yazan F., Patel, Prapti A., Collins, Robert H., Blum, William, Arellano, Martha, Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor J., Olin, Rebecca, Curran, Emily K, Stein, Eytan M., Schiller, Gary J., Zeidner, Joshua F., Redner, Robert L., Heerema, Nyla A., Martycz, Molly, Rosenberg, Leonard, Marcus, Sonja Gullen, Chen, Timothy, Stefanos, Mona, Levine, Ross L, Druker, Brian J., Yocum, Ashley Owen, Burd, Amy, Mims, Alice, Borate, Uma M., Byrd, John C., Traer, Elie
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Genomic Characterization of Newly Diagnosed Acute Myeloid Leukemia in Patients Age 60 Years and Older; A Report from the Beat AML Master Trial
Hoff, Fieke W, Huang, Ying, Welkie, Rina Li, Swords, Ronan T., Traer, Elie, Stein, Eytan M., Lin, Tara L, Patel, Prapti A., Collins, Robert H., Baer, Maria R., Duong, Vu H., Blum, William, Arellano, Martha, Stock, Wendy, Odenike, Olatoyosi, Redner, Robert L., Kovacsovics, Tibor J., Deininger, Michael W., Zeidner, Joshua F., Olin, Rebecca, Smith, Catherine C., Foran, James M., Schiller, Gary J., Curran, Emily K, Koenig, Kristin L, Heerema, Nyla A., Chen, Timothy, Martycz, Molly, Stefanos, Mona, Marcus, Sonja Gullen, Rosenberg, Leonard, Druker, Brian J., Levine, Ross L, Burd, Amy, Yocum, Ashley Owen, Borate, Uma M., Mims, Alice, Byrd, John C., Madanat, Yazan F.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Influence of Pre-Treatment Features and Therapy Choice By Physicians on Overall Survival in Older Adults with Acute Myeloid Leukemia: A Report from the Beat AML Master Trial
Borate, Uma M., Huang, Ying, Welkie, Rina Li, Swords, Ronan T., Traer, Elie, Stein, Eytan M., Lin, Tara L, Madanat, Yazan F., Patel, Prapti A., Collins, Robert H., Baer, Maria R., Duong, Vu H., Blum, William, Arellano, Martha, Stock, Wendy, Odenike, Olatoyosi, Redner, Robert L., Kovacsovics, Tibor J., Deininger, Michael W., Zeidner, Joshua F., Olin, Rebecca, Smith, Catherine C., Foran, James M., Schiller, Gary J., Curran, Emily K, Koenig, Kristin L, Heerema, Nyla A., Chen, Timothy, Martycz, Molly, Stefanos, Mona, Marcus, Sonja Gullen, Rosenberg, Leonard, Druker, Brian J., Levine, Ross L, Burd, Amy, Yocum, Ashley Owen, Mims, Alice, Byrd, John C.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML)
Zeidner, Joshua F., Foster, Matthew C., Johnson, Mary, Huang, Ying, Swords, Ronan T., Stein, Eytan, Foran, James M., Baer, Maria R., Stock, Wendy, Madanat, Yazan F., Kovacsovics, Tibor, Olin, Rebecca L., Blum, William G., Schiller, Gary J., Lin, Tara L., Redner, Robert L., Al-Mansour, Zeina, Curran, Emily K, Heerema, Nyla A., Martycz, Molly, Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O., Chen, Timothy, Stefanos, Mona, Druggan, Franchesca, Burd, Amy, Levine, Ross L., Druker, Brian J., Borate, Uma, Byrd, John C., Mims, Alice S.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up
Stein, Eytan, Cai, Sheng F, Huang, Ying, Dunbar, Andrew, Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William G., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark R., Lin, Tara L., Patel, Prapti A., Foster, Matthew C., Boyiadzis, Michael M., Collins, Robert H., Chervin, Jordan, Shoben, Abigail B., Vergilio, Jo-Anne, Heerema, Nyla A., Rosenberg, Leonard, Chen, Timothy, Yocum, Ashley O., Druggan, Franchesca, Marcus, Sonja, Stefanos, Mona, Martycz, Molly, Druker, Brian J., Mims, Alice S., Borate, Uma, Burd, Amy, Byrd, John C., Levine, Ross L.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Entospletinib (ENTO) in Combination with Cytarabine (Ara-C) and Daunorubicin (DNR) in Newly Diagnosed (ND) Adult Patients with NPM1-Mutated and FLT3-ITD Wild-Type Acute Myeloid Leukemia (AML) Is Associated with Good Response and Survival: A Phase 2 Sub-Study of the Beat AML Master Trial
Borate, Uma, Li, Rui, Huang, Ying, Swords, Ronan T., Traer, Elie, Stein, Eytan, Foran, James M., Baer, Maria R., Duong, Vu H., Stock, Wendy, Odenike, Olatoyosi, Patel, Prapti, Collins, Robert H., Madanat, Yazan F., Kovacsovics, Tibor, Deininger, Michael W., Smith, Catherine, Olin, Rebecca L., Arellano, Martha L., Blum, William G., Schiller, Gary J., Lin, Tara L., Foster, Matthew C., Boyiadzis, Michael M., Redner, Robert L., Al-Mansour, Zeina, Curran, Emily K, Heerema, Nyla A., Gana, Theophilus J, Martycz, Molly, Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O., Chen, Timothy, Stefanos, Mona, Druggan, Franchesca, Burd, Amy, Levine, Ross L., Druker, Brian J., Byrd, John C., Mims, Alice S.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Duong, Vu H., Ruppert, Amy S., Mims, Alice S., Borate, Uma, Stein, Eytan M., Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William, Arellano, Martha L., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark R., Lin, Tara L., Patel, Prapti A., Foster, Matthew C., Redner, Robert L., Al‐Mansour, Zeina, Cogle, Christopher R., Swords, Ronan T., Collins, Robert H., Vergilio, Jo‐Anne, Heerema, Nyla A., Rosenberg, Leonard, Yocum, Ashley O., Marcus, Sonja, Chen, Timothy, Druggan, Franchesca, Stefanos, Mona, Gana, Theophilus J., Shoben, Abigail B., Druker, Brian J., Burd, Amy, Byrd, John C., Levine, Ross L., Boyiadzis, Michael M.
Published in Cancer (01.08.2023)
Published in Cancer (01.08.2023)
Get full text
Journal Article
Gilteritinib (GILT) Monotherapy with Addition of Decitabine (DEC) in Non-Responders in Older Newly Diagnosed (ND) FLT3 Mutated Acute Myeloid Leukemia (AML) Patients Having High and Low Variant Allele Frequency (VAF): A Phase 2/1b Sub-Study of the Beat AML Master Trial
Traer, Elie, Huang, Ying, Mims, Alice S., Stein, Eytan M., Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William, Arellano, Martha L., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark R., Lin, Tara L., Patel, Prapti, Foster, Matthew C., Redner, Robert L., Al-Mansour, Zeina, Cogle, Christopher R., Boyiadzis, Michael M., Swords, Ronan, Collins, Robert H., Vergilio, Jo-Anne, Heerema, Nyla A., Rosenberg, Leonard, Yocum, Ashley O., Marcus, Sonja, Chen, Timothy, Druggan, Franchesca, Stefanos, Mona, Gana, Theophilus J, Shoben, Abigail B., Druker, Brian J., Burd, Amy, Byrd, John C., Levine, Ross L., Borate, Uma
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Entospletinib (ENTO) and Decitabine (DEC) Combination Therapy in Older Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Patients with Mutant TP53 or Complex Karyotype Is Associated with Poor Response and Survival: A Phase 2 Sub-Study of the Beat AML Master Trial
Duong, Vu H., Ruppert, Amy S., Mims, Alice S., Borate, Uma, Stein, Eytan M., Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William G., Arellano, Martha L., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark R., Lin, Tara L., Patel, Prapti A., Foster, Matthew C., Redner, Robert L., Al-Mansour, Zeina, Cogle, Christopher R., Swords, Ronan T., Collins, Robert H., Vergilio, Jo-Anne, Heerema, Nyla A., Rosenberg, Leonard, Yocum, Ashley O., Marcus, Sonja, Chen, Timothy, Druggan, Franchesca, Stefanos, Mona, Gana, Theophilus J, Shoben, Abigail B., Druker, Brian J., Burd, Amy, Byrd, John C., Levine, Ross L., Boyiadzis, Michael M.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Ivosidenib (IVO) in Combination with Azacitidine (AZA) in Newly Diagnosed (ND) Older Patients with IDH1 R132-Mutated Acute Myeloid Leukemia (AML) Induces High Response Rates: A Phase 2 Sub-Study of the Beat AML Master Trial
Patel, Prapti, Ruppert, Amy S., Borate, Uma, Stein, Eytan M., Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William, Arellano, Martha L., Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark R., Lin, Tara L., Foster, Matthew C., Redner, Robert L., Al-Mansour, Zeina, Cogle, Christopher R., Boyiadzis, Michael M., Swords, Ronan, Collins, Robert H., Vergilio, Jo-Anne, Heerema, Nyla A., Rosenberg, Leonard, Yocum, Ashley Owen, Marcus, Sonja, Chen, Timothy, Druggan, Franchesca, Stefanos, Mona, Gana, Theophilus J, Shoben, Abigail B., Druker, Brian J., Burd, Amy, Byrd, John C., Levine, Ross L., Mims, Alice S.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Enasidenib (ENA) Monotherapy with Addition of Azacitidine in Non-Responders Is Effective in Older Patients with Newly Diagnosed IDH2 Mutated Acute Myeloid Leukemia (AML): A Completed Phase 2/1b Sub-Study of the Beat AML Master Trial
Stein, Eytan M., Huang, Ying, Borate, Uma, Baer, Maria R., Stock, Wendy, Kovacsovics, Tibor, Blum, William, Schiller, Gary J., Olin, Rebecca L., Foran, James M., Litzow, Mark, Lin, Tara, Patel, Prapti A., Foster, Matthew C, Boyiadzis, Michael, Collins, Robert H., Vergilio, Jo-Anne, Heerema, Nyla A, Rosenberg, Leonard, Yocum, Ashley Owen, Chen, Timothy, Druggan, Franchesca, Marcus, Sonja, Stefanos, Mona, Chervin, Jordan, Shoben, Abigail, Druker, Brian J., Burd, Amy, Byrd, John C., Levine, Ross L., Mims, Alice S.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article